Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The protein boost will also help you manage another potential side effect hair loss
S6 show that both GLP-1RA and SGLT-2 inhibitors were associated with a lower risk (13% and 14%, respectively) as compared with placebo and DPP-4 inhibitors (11% and 12%, respectively), although the difference in risks was significant for SGLT-2 vs DPP-4 inhibitors only
Improved tolerability could therefore become an important competitive advantage if these findings translate successfully into clinical studies
Results: Findings from 60 studies and safety reports were included
Monitoring plan : Agree on a schedule for follow-up appointments, blood tests (including HbA1c, renal function, and inflammatory markers), and faecal calprotectin if appropriate
